Skip to content

ALPMY Astellas Pharma Inc Unsponsore

Follow

USD (ADR)

7 managers (7 13F filers) reported a position in ALPMY shares at 2026-03-31, 284,634 shares in all. 0 filers opened a position and 1 filer sold out during the quarter.

Managers
7
13F filers
7
New
0
Added
3
Reduced
3
Sold out
1
Shares held by filers
284,634

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2026

Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
HANTZ FINANCIAL SERVICES, INC.200,698$3.25M0.05%-16,73413F-HRTimelineThe filing omitted confidential holdings, a later amendment may add them.
LANARK FINANCIAL, INC.44,856$710K0.05%-6,50413F-HRTimeline
RHUMBLINE ADVISERS21,804$354K<0.01%-1,60413F-HRTimeline
GAMMA Investing LLC12,771$207K0.01%+1,93113F-HRTimeline
Salomon & Ludwin, LLC2,432$40.1K<0.01%+1,69813F-HRTimeline
WELLINGTON-ALTUS USA INC.2,017$27K0.02%+53113F-HRTimeline
PNC Financial Services Group, Inc.in group PNC Financial Services Group,…56$908<0.01%013F-HRTimelineGroup